medigraphic.com

2024, Number 4

<< Back Next >>

Rev Educ Bioquimica 2024; 43 (4)

Características de la senescencia celular en el tejido hepático en salud y enfermedad

Delgado CBA

Language: Spanish
References: 33
Page: 235-344
PDF size: 708.83 Kb.


ABSTRACT

The liver is an active organ which under normal conditions is quiescent, but under different stimuli, it can overcome that stage. In general, over the years cells permanently lose their proliferative capacity and display important phenotypic changes as well as several alterations in intracellular mechanisms relevant to the appropriate cell function. Together, these alterations are known as cellular senescence. Here, the role of senescence in health and disease processes in the liver tissue is analyzed.


REFERENCES

  1. Delgado-Coello B. Liver regenerationobserved across the different classes of vertebratesfrom an evolutionary perspective. Heliyon. 2021; 7(3):e06449.

  2. Hayflick L, Moorehead PS. The serialcultivation of human diploid cell strains.Experimental Cell Res. 1961; 25(3):585-621.

  3. Kumari R, Jat P. Mechanisms of cellularsenescence; cell cycle arrest and senescenceassociated secretory phenotype. Front Cell DevBiol. 2021; 9:645593.

  4. Wijayasiri P, Astbury S, Kaye P, Oakley F,Alexander GJ, Kendall TJ, Aravinthan AD. Role ofhepatocyte senescence in the activation of hepaticstellate cells and liver fibrosis progression. Cells.2022; 11(4):2221.

  5. Suda K, Moriyama Y, Razali N, Chiu Y,Masukagami Y, Nishimura K, Barbee H, Takase H,Sugiyama S, Yamazaki Y, Sato Y, Higashiyama T,Johmura Y, Nakanishi M, Kono K. Plasmamembrane damage limits replicative lifespan inyeast and induces premature senescence in humanfibroblasts. Nat Aging. 2024; 4(3):319-335.

  6. Kuehnemann C, Wiley CD. Senescent cells atthe crossroads of aging, disease, and tissuehomeostasis. Aging Cell. 2024; 23:e13988.

  7. Muñoz-Espín D, Cañamero M, Maraver A,Gómez-López G, Contreras J, Murillo-Cuesta S,Rodríguez-Baeza A, Varela-Nieto I, Ruberte J,Collado M, Serrano M. Programmed cellsenescence during mammalian embryonicdevelopment. Cell. 2013; 155:1104-1118.

  8. Mitaka T, Ichinohe N, Tanimizu N. “Smallhepatocytes” in the liver. Cells. 2023; 12:2718.

  9. Paradis V, Youssef N, Dargère D, Bâ N,Bonvoust F, Deschatrette J, Bedossa P. Replicativesenescence in normal liver, chronic hepatitis C, andhepatocellular carcinomas. Human Pathol. 2001;32(3):327-332.

  10. Huda N, Liu G, Hong H, Yan S, Khambu B,Yin X-M. Hepatic senescence, the good and the bad.World J Gastroenterol. 2019; 25(34):5069-5081.

  11. Herranz N, Gil J. Mechanisms and function ofcellular senescence. J Clin Invest. 2018;128(4):1238-1246.

  12. Irvine KM, Skoien R, Bokil NJ, Melino M,Thomas GP, Loo D, Gabrielli B, Hill MM, SweetMJ, Clouston AD, Powell EE. Senescent humanhepatocytes express a unique secretory phenotypeand promote macrophage migration. World JGastroenterol. 2014; 20(47):17851-17862.

  13. Singh BJ, Tripathi M, Sandureddy R, Tikno K,Zhou J, Yen PM. Decreased autophagy and fuelswitching occur in a senescent hepatic cell modelsystem. Aging. 2020; 12(14):13958-13978.

  14. Ma Y, Liang Y, Liang N, Zhang Y, Xiao F.Identification and functional analysis of senescence-associated secretory phenotype of prematuresenescent hepatocytes induced by hexavalentchromium. Ecotoxicol Environ Saf. 2021;211:111908.

  15. Muthamil S, Kim H-Y, Jang H-J, Lyu J-H, ShinUC, Go Y, Park S-H, Lee HG, Park JH. Biomarkersof senescence and aging: current state-of-the-art.Challenges and future perspectives. Adv Biol. 2024;8:2400079.

  16. Yang N, Occean JR, Melters DP, Shi C, WangL, Stransky S, Doyle ME, Cui C-Y, Delannoy M,Fan J, Slama E, Egan JM, De S, Cunningham SC,de Cabo R, Sidoli S, Dalal Y, Sen P. A hyper-quiescent chromatin state formed during aging isreversed by regeneration. Mol Cell. 2023;83(10):1659-1676.

  17. Chaib S, Tchkonia T, Kirkland JL. Cellularsenescence and senolytics: the path to clinic. NatMed. 2022; 28:1556-1568.

  18. Ferreira-Gonzalez S, Rodrigo-Torres D, GadVL, Forbes SJ. Cellular senescence in liver diseaseand regeneration. Semin Liver Dis. 2021; 41:50-66.

  19. Zhang M, Serna-Salas S, Damba T, BorghesanM, Demaria M, Moshage H. Hepatic stellate cellsenescence in liver fibrosis: characteristics,mechanisms and perspectives. Mech Ageing Dev.2021; 199:111572.

  20. Yoshimoto S, Loo TM, Atarashi K, Kanda H,Sato S, Oyadomari S, Iwakura Y, Oshima K, MoritaH, Hattori M, Honda K, Ishikawa Y, Hara E, OhtaniN.Obesity-induced gut microbial metabolitepromotes liver cancer through senescencesecretome. Nature. 2013; 499(7456):97-101.

  21. Tsuchida T, Friedman SL. Mechanisms ofhepatic stellate cell activation. Nat RevGastroenterol Hepatol. 2017; 14(7):397-411.

  22. Kong X, Feng D, Wang H, Hong F, Bertola A,Wang F-S, Gao B. Interleukin-22 induces hepaticstellate cell senescence and restricts liver fibrosis inmice. Hepatology. 2012; 56(3):1150-1159.

  23. Chen E, Cen Y, Lu D, Luo W, Jiang H. IL-22inactivates hepatic stellate cells via downregulationof the TGF-ß1/Notch signaling pathway. Mol MedRep. 2018; 17:5449-5453.

  24. Yashaswini CN, Qin T, Bhattacharya D, AmorC, Lowe S, Lujambio A, Wang S, Friedman SL.Phenotypes and ontogeny of senescent hepaticstellate cells in metabolic dysfunction-associatedsteatohepatitis. J Hepatol. 2024; 81(2):207-217.

  25. Ferreira-Gonzalez S, Man TY, Esser H, Aird R,Kilpatrick AM, Rodrigo-Torres D, Younger N,Campana L, Gadd VL, Dwyer B, Aleksieva N,Boulter L, Macmillan MT, Wang Y, Mylonas KJ,Ferenbach DA, Kendall TJ, Lu W-Y, Acosta JC,Kurian D, O´Neill S, Onicsu GC, Banales JM,Krimpenfort PJ, Forbes SJ. Senolytic treatmentpreserves biliary regenerative capacity lost throughcellular senescence during cold storage. Sci TranslMed. 2022; 14:eabj4375.

  26. Justice JN, Nambiar AM, Tchkonia T,LeBrasseur NK, Pascual R, HashmI SK, Prata L,Masternak MM, Kritchevsky SB, Musi N, KirklandJL. Senolytics in idiopathic pulmonary fibrosis:Results from a first-in-human, open-label, pilotstudy. EBioMedicine. 2019; 40:554-563.

  27. Hickson LJ, Langhi Prata LGP, Bobart SA,Evans TK, Giorgadze N, Hashmi SK, HerrmannSM, Jensen MD, Jia Q, Jordan KL, Kellogg TA,Khosla S, Koerber DM, et al. Senolytics decreasesenescent cells in humans: Preliminary report froma clinical trial of Dasatinib plus Quercetin inindividuals with diabetic kidney disease.EBioMedicine. 2019; 47:446-456.

  28. Gonzales MM, Garbarino VR, Kautz TF,Palavicini JP, Lopez-Cruzan M, Dehkordi SK,Mathews JJ, Zare H, Xu P, Zhang B, Franklin C,Habes M, Craft S, Petersen RC, Tchkonia T,Kirkland JL, Salardini A, Seshadri S, Musi N, OrrME. Senolytic therapy in mild Alzheimer’s disease:a phase 1 feasibility trial. Nat Med. 2023; 29:2481-2488.

  29. Jannone G, Bonaccorsi Riani E, de Magnée C,Tambucci R, Evraerts J, Ravau J, Baldin P, BouzinC, Loriot A, Gatto L, Decottignies A, Najimi M,Sokal EM. Senescence and senotherapies in biliaryatresia and biliary cirrhosis. Aging (Albany NY).2023; 15(11):4576-4599.

  30. Pacheco-Rivera R, Fattel-Fazenda S,Arellanes-Robledo J, Silva-Olivares A, Alemán-Lazarini L, Rodríguez-Segura M, Pérez-Carreón J,Villa-Treviño S, Shibayama M, Serrano-Luna J.Double staining of ß-galactosidase with fibrosis andcancer markers reveals the chronologicalappearance of senescence in liver carcinogenesisinduced by diethylnitrosamine. Toxicol Lett. 2016;241:19-31.

  31. Wiemann SU, S Satyanarayana A, TsahuriduM, Tillmann HL, Zender L, Klempnauer J,Flemming P, Franco S, Blasco MA, Manns MP,Rudolph KL. Hepatocyte telomere shortening andsenescence are general markers of human livercirrhosis. FASEB J. 2002; 16:935-942.

  32. Ferreira-Gonzalez S, Lu WY, Raven A, DwyerB, Man TY, O'Duibhir E, Lewis PJS, Campana L,Kendall TJ, Bird TG, Tarrats N, Acosta JC, BoulterL, Forbes SJ. Paracrine cellular senescenceexacerbates biliary injury and impairs regeneration.Nat Commun. 2018; 9(1):1020.

  33. Wang Y, Qiu H, Chen S, Li D, Zhao X, Guo M,Li N, Chen C, Qin M, Zhou Y, Xiao D, Zhao J, XuL.MicroRNA-7 deficiency ameliorates D-galactose-induced aging in mice by regulatingsenescence in Kupffer cells. Aging Cell. 2024;e14145.




2020     |     www.medigraphic.com